GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,000 | -3.6% | 46,340 | +9.4% | 0.00% | – |
| Q2 2023 | $83,000 | +9.2% | 42,340 | +54.9% | 0.00% | – |
| Q1 2023 | $76,000 | -22.4% | 27,340 | -3.5% | 0.00% | – |
| Q4 2022 | $98,000 | +46.3% | 28,340 | +7.6% | 0.00% | – |
| Q3 2022 | $67,000 | +11.7% | 26,340 | +6.0% | 0.00% | – |
| Q2 2022 | $60,000 | -41.2% | 24,840 | 0.0% | 0.00% | – |
| Q1 2022 | $102,000 | -61.5% | 24,840 | +22.1% | 0.00% | -100.0% |
| Q4 2021 | $265,000 | -24.7% | 20,351 | -37.7% | 0.00% | 0.0% |
| Q3 2021 | $352,000 | +8.3% | 32,690 | -8.3% | 0.00% | 0.0% |
| Q2 2021 | $325,000 | +3.2% | 35,640 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $315,000 | +238.7% | 33,400 | +42.1% | 0.00% | – |
| Q4 2020 | $93,000 | +86.0% | 23,500 | +23.7% | 0.00% | – |
| Q3 2020 | $50,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |